Journal of AOAC International 2011-01-01

Development and validation of a reversed-phase ultra-performance liquid chromatographic method for assay of lacidipine and related substances.

Arivozhi Mohan, Hitesh B Patel, Dhandayutham Saravanan

Index: J. AOAC Int. 94(6) , 1800-6, (2011)

Full Text: HTML

Abstract

A simple isocratic, RP-ultra-performance LC method was developed and validated for the determination of lacidipine, three process impurities formed during synthesis, and three degradation products present in drug substance and the drug product. An efficient chromatographic separation was achieved on an Acquity BEH C18 column using pH 4.5 ammonium acetate-acetic acid buffer-methanol (70 + 30, v/v) mobile phase. The monitoring wavelength was 240 nm, and the flow rate 0.25 mL/min. Forced degradation studies using acid, alkali, peroxide, water, heat, and light were conducted, and all impurities were separated. The method was validated successfully for specificity, precision, linearity, accuracy, LOD, LOQ, and robustness, according to International Conference on Harmonization guidelines. The linearity of the calibration curve for lacidipine and each impurity was found to be very good (r2 > 0.999). This method is shown to be suitable for analysis of lacidipine to evaluate the quality of drug substance and a drug product.


Related Compounds

Related Articles:

Possible hepatoprotective effects of lacidipine in irradiated DOCA-salt hypertensive albino rats.

2013-11-01

[Pak. J. Biol. Sci. 16(21) , 1353-7, (2013)]

Effect of long-term antihypertensive treatment on white-coat hypertension.

2014-12-01

[Hypertension 64(6) , 1388-98, (2014)]

Ordered mesoporous silica material SBA-15: loading of new calcium channel blocker--lacidipine.

2013-01-01

[J. Microencapsul. 30(1) , 21-7, (2013)]

The protective effects of metyrosine, lacidipine, clonidine, and moxonidine on kidney damage induced by unilateral ureteral obstruction in rats.

2012-11-01

[Surg. Today 42(11) , 1051-60, (2012)]

The cardiac and vascular effects of lacidipine.

1995-01-01

[J. Cardiovasc. Pharmacol. 25 Suppl 3 , S1-5, (1995)]

More Articles...